Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer

人类癌症中 STAG2 失活和非整倍性分析

基本信息

  • 批准号:
    8633441
  • 负责人:
  • 金额:
    $ 31.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-03-07 至 2018-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): One of the most common features that distinguishes cancer cells from normal cells is the presence of aneuploidy. We have recently discovered a cause of aneuploidy in a substantial fraction of malignant human tumors - deletions, somatic mutations, and loss of expression of the STAG2 gene (Science 336:1039-1043, 2011). The encoded STAG2 protein is a key component of the multi-protein cohesin complex which regulates sister chromatid cohesion and helps ensure faithful chromosome segregation during mitosis. In this grant we propose a multi-faceted effort to further define the mechanism through which STAG2 inactivation leads to chromosomal instability, aneuploidy, and cancer. In Aim #1 we will evaluate the effects of tumor-derived mutations in STAG2 on sister chromatid cohesion and protein-protein interactions. The goal is to functionally evaluate mutations in STAG2 to reveal the key activities of STAG2 that are lost during tumorigenesis. In Aim #2 we will determine the effect of STAG2 truncating mutations on the protein composition of cohesin and its ability to interact with chromatin at different phases of the cell cycle. These experiments wil enable us to identify key mechanisms by which STAG2 inactivation leads to chromosomal instability and aneuploidy. In Aim #3 we will determine the role of STAG2 inactivation on the initiation and maintenance of transformation in human astrocytes and GBM cells. These experiments will enable us to determine if STAG2 inactivation results in enhanced susceptibility to malignant transformation. In Aim #4 we will determine if mutations in STAG2 cause GBM cells to be sensitized to ionizing radiation and DNA damaging chemotherapeutic drugs. The broad goal of the proposed research program is to determine the mechanism through which STAG2 inactivation leads to chromosomal instability, aneuploidy, and cellular transformation, making it possible to develop strategies for identifying novel anticancer therapeutics that specifically target aneuploid cells.
描述(由申请人提供):将癌细胞与正常细胞区分开来的最常见特征之一是存在非整倍体。我们最近在相当一部分恶性人类肿瘤中发现了非整倍体的原因——缺失、体细胞突变和STAG2基因表达缺失(Science 336:1039-1043, 2011)。编码的STAG2蛋白是多蛋白内聚复合物的关键组成部分,它调节姐妹染色单体内聚并帮助确保有丝分裂过程中染色体的忠实分离。在这项资助中,我们提出了多方面的努力,以进一步确定STAG2失活导致染色体不稳定、非整倍体和癌症的机制。在目标1中,我们将评估肿瘤来源的STAG2突变对姐妹染色单体内聚和蛋白-蛋白相互作用的影响。目的是对STAG2突变进行功能评估,以揭示在肿瘤发生过程中丢失的STAG2关键活性。在Aim #2中,我们将确定STAG2截断突变对内聚蛋白的蛋白质组成及其在细胞周期不同阶段与染色质相互作用的能力的影响。这些实验将使我们能够确定STAG2失活导致染色体不稳定和非整倍体的关键机制。在Aim #3中,我们将确定STAG2失活在人类星形胶质细胞和GBM细胞中转化的启动和维持中的作用。这些实验将使我们能够确定STAG2失活是否会导致恶性转化的易感性增强。在Aim #4中,我们将确定STAG2突变是否会导致GBM细胞对电离辐射和DNA损伤化疗药物敏感。该研究计划的总体目标是确定STAG2失活导致染色体不稳定、非整倍体和细胞转化的机制,从而有可能开发出专门针对非整倍体细胞的新型抗癌疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TODD A WALDMAN其他文献

TODD A WALDMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TODD A WALDMAN', 18)}}的其他基金

Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
人类癌症中 STAG2 失活和非整倍性分析
  • 批准号:
    8501829
  • 财政年份:
    2013
  • 资助金额:
    $ 31.3万
  • 项目类别:
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
人类癌症中 STAG2 失活和非整倍性分析
  • 批准号:
    8819107
  • 财政年份:
    2013
  • 资助金额:
    $ 31.3万
  • 项目类别:
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
人类癌症中 STAG2 失活和非整倍性分析
  • 批准号:
    9008028
  • 财政年份:
    2013
  • 资助金额:
    $ 31.3万
  • 项目类别:
Development and Application of Endogenous Epitope Tagging Technology in Human Cel
人细胞内源表位标记技术的开发及应用
  • 批准号:
    7777680
  • 财政年份:
    2010
  • 资助金额:
    $ 31.3万
  • 项目类别:
Development and Application of Endogenous Epitope Tagging Technology in Human Cel
人细胞内源表位标记技术的开发及应用
  • 批准号:
    8044714
  • 财政年份:
    2010
  • 资助金额:
    $ 31.3万
  • 项目类别:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
人类癌细胞中 PTEN 依赖性大小检查点
  • 批准号:
    7417921
  • 财政年份:
    2006
  • 资助金额:
    $ 31.3万
  • 项目类别:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
人类癌细胞中 PTEN 依赖性大小检查点
  • 批准号:
    7685028
  • 财政年份:
    2006
  • 资助金额:
    $ 31.3万
  • 项目类别:
A PTEN-Dependent Size Checkpoint in Human Cancer Cells
人类癌细胞中 PTEN 依赖性大小检查点
  • 批准号:
    7105903
  • 财政年份:
    2006
  • 资助金额:
    $ 31.3万
  • 项目类别:
A PTEN-dependent cell size checkpoint in human cells
人类细胞中 PTEN 依赖性细胞大小检查点
  • 批准号:
    8690786
  • 财政年份:
    2006
  • 资助金额:
    $ 31.3万
  • 项目类别:
A PTEN-dependent cell size checkpoint in human cells
人类细胞中 PTEN 依赖性细胞大小检查点
  • 批准号:
    8578465
  • 财政年份:
    2006
  • 资助金额:
    $ 31.3万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 31.3万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 31.3万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 31.3万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 31.3万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 31.3万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 31.3万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 31.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 31.3万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 31.3万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 31.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了